# A Phase I Study of GZR18 Injection in Obese/Overweight Subjects

> **NCT06548945** · PHASE1 · COMPLETED · sponsor: **Gan and Lee Pharmaceuticals, USA** · enrollment: 16 (actual)

## Conditions studied

- Overweight and Obesity

## Interventions

- **DRUG:** GZR18
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06548945
- **Lead sponsor:** Gan and Lee Pharmaceuticals, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-25
- **Primary completion:** 2023-08-14
- **Final completion:** 2023-08-14
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06548945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06548945, "A Phase I Study of GZR18 Injection in Obese/Overweight Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06548945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*